{
  "content": "63FJ Martinez-Marcos, JL Garcia-Garmendia, A Ortega-Carpio, JM Fernandez-Gomez, JM Santos, C Camacho Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm  Am J Cardiol, 86 (2000), pp. 950-953 View PDFView articleView in ScopusGoogle Scholar \n64P Chevalier, A Durand-Dubief, H Burri, M Cucherat, G Kirkorian, P Touboul Amiodarone versus placebo and class 1C drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis  J Am Coll Cardiol, 41 (2003), pp. 255-262 View PDFView articleView in ScopusGoogle Scholar",
  "source": "https://www.sciencedirect.com/science/article/pii/S0002914920300060",
  "chunk_id": "1072a49b-c3e8-42cc-b241-a8884e466003",
  "similarity_score": 0.3275262117385864,
  "query": "amiodarone efficacy cardioversion atrial fibrillation success rate beta-blockers metoprolol propranolol carvedilol",
  "rank": 28,
  "title": "Use of flecainide for the treatment of atrial fibrillation",
  "authors": "Debra S. Echt, Jeremy N. Ruskin",
  "year": "2020",
  "journal": "The American Journal of Cardiology",
  "reference": "Echt, D. S., & Ruskin, J. N. (2020). Use of flecainide for the treatment of atrial fibrillation. The American Journal of Cardiology, 125(7), 1123-1133. https://doi.org/10.1016/j.amjcard.2019.12.041",
  "doi": "10.1016/j.amjcard.2019.12.041",
  "chunk_index": 105,
  "total_chunks": 143,
  "retrieved_at": "2025-07-24T21:57:47.296241"
}